Allosteric modulators restore orthosteric agonist binding to mutated CB₁ receptors

Area of Science:

• Pharmacology
• Molecular Biology
• Biochemistry

Background:

• Mutations in cannabinoid receptor 1 (CB₁) extracellular loops can impair orthosteric agonist binding.
• Understanding these impairments is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate if allosteric modulators can restore orthosteric agonist binding to mutated CB₁ receptors.
• To explore the therapeutic potential of allosteric modulators for CB₁ receptor dysfunction.

Main Methods:

• Binding assays were conducted using varying concentrations of orthosteric compounds.
• The effect of allosteric modulators (PSNCBAM-1, ORG27569) on agonist binding to wild-type and mutated CB₁ receptors was assessed.

Main Results:

• Single mutations in CB₁ extracellular loops 1 or 2 significantly reduced or abolished agonist (CP55940) binding.
• The allosteric modulator PSNCBAM-1 restored CP55940 binding to near wild-type levels in mutated CB₁ receptors.
• Another allosteric modulator, ORG27569, also demonstrated the ability to restore binding.

Conclusions:

• Allosteric modulators show therapeutic promise for restoring function in mutated receptors where orthosteric binding is compromised.
• This study provides evidence for the utility of allosteric modulators in addressing CB₁ receptor-related functional deficits.